Show simple item record

dc.contributor.authorEini, Maryam
dc.contributor.authorParsi, Sepideh
dc.contributor.authorBarati, Mahmood
dc.contributor.authorBahramali, Golnaz
dc.contributor.authorAlizadeh Zarei, Marziyeh
dc.contributor.authorKiani, Jafar
dc.contributor.authorAzarnezhad, Assad
dc.contributor.authorHosseini, Arshad
dc.date.accessioned2023-09-06T19:31:58Z
dc.date.available2023-09-06T19:31:58Z
dc.date.issued2022-04-01
dc.identifier.citationEini M, Parsi S, Barati M, Bahramali G, Alizadeh Zarei M, Kiani J, Azarnezhad A, Hosseini A. Bioinformatic Investigation of Micro RNA-802 Target Genes, Protein Networks, and Its Potential Prognostic Value in Breast Cancer. Avicenna J Med Biotechnol. 2022 Apr-Jun;14(2):154-164. doi: 10.18502/ajmb.v14i2.8882. PMID: 35633990; PMCID: PMC9077654.en_US
dc.identifier.issn2008-2835
dc.identifier.doi10.18502/ajmb.v14i2.8882en_US
dc.identifier.pmid35633990
dc.identifier.urihttp://hdl.handle.net/20.500.14038/52468
dc.description.abstractBackground: An increasing number of studies have suggested that unveiling the molecular network of miRNAs may provide novel therapeutic targets or biomarkers. In this study, we investigated the probable molecular functions that are related to microRNA-802 (miR-802) and evaluated its prognostic value in breast cancer utilizing bioinformatics tools. Methods: PPI network, pathway enrichment and transcription factor analysis were applied to obtain hub genes among overlapping genes of four miRNA target prediction databases. Prognosis value assessments and expression analysis of hub genes using bioinformatics tools, as well as their literature validation were performed. Results: Our results showed a significant correlation of the miR-802 overexpression with poor patient survival rate (BC, p=2.7e-5). We determined 247 target genes significant for GO and KEGG terms. Analysis of TFs by TRUST showed that RUNX3, FOXO3, and E2F1 are possible TFs that regulate the miR-802 expression and target genes network. According to our analysis; 21 genes might have an important function in miR-802 molecular processes and regulatory networks. The result shows that among these 21 genes, 8 genes (CASC3, ITGA4, AGO3, TARDBP, MED13L, SF1, SNRPE and CRNKL1) are positively correlated with patient survival. Therefore these genes could be considered and experimentally evaluated as a prognostic biomarker for breast cancer. Conclusion: The comprehensive bioinformatics study on miR-802 target genes provided insight into miR-802 mediated pathways and processes. Furthermore, representing candidate target genes by prognostic values indicates the potential clinical application of miR-802 in breast cancer.en_US
dc.language.isoenen_US
dc.relation.ispartofAvicenna Journal of Medical Biotechnologyen_US
dc.relation.urlhttps://doi.org/10.18502/ajmb.v14i2.8882en_US
dc.rightsThis work is licensed under a Creative Commons Attribution –NonCommercial 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.en_US
dc.rightsAttribution-NonCommercial 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectBioinformaticsen_US
dc.subjectBreast canceren_US
dc.subjectCell cycleen_US
dc.subjectPrognosisen_US
dc.subjectWnt signalingen_US
dc.subjectmiR-802en_US
dc.titleBioinformatic Investigation of Micro RNA-802 Target Genes, Protein Networks, and Its Potential Prognostic Value in Breast Canceren_US
dc.typeJournal Articleen_US
dc.source.journaltitleAvicenna journal of medical biotechnology
dc.source.volume14
dc.source.issue2
dc.source.beginpage154
dc.source.endpage164
dc.source.countryIran
dc.identifier.journalAvicenna journal of medical biotechnology
refterms.dateFOA2023-09-06T19:32:01Z
dc.contributor.departmentBiochemistry and Molecular Biotechnologyen_US


Files in this item

Thumbnail
Name:
document.pdf
Size:
1.275Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

This work is licensed under a Creative Commons Attribution –NonCommercial 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
Except where otherwise noted, this item's license is described as This work is licensed under a Creative Commons Attribution –NonCommercial 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.